Great, that’s a start! I will take that as license to brain-dump here then 
Of note, I will speak from personal observation & talks with the larger group of Open Insulin Project collaborators, but would not say that I speak for them. So @winnieponcelet @dfko @thomasmboa please feel free to jump in too!
I think a big theme would be around having a global strategy for local production for Open Insulin. What we have talked about here and in other fora is the idea that localized production would be key in spreading the technology or group intelligence, that the scientists and others are working on across physical and cultural boundaries. The collective knowledge, the means of production, can be seen as capital that can be used appropriately in hyperlocal economic and cultural contexts. What this allows for is creating unique meaning to how the technology is to be deployed without any one person or entity to the actual mode of distribution, which is crucial to open science. No one can horde the technology in an ideal sharing situation.
Here is a quote from a post that I read recently that I have been thinking about a lot as to the power of the open insulin project (really good read, especially midway, about cosmolocalism):
“Fablabs, makerspaces, emerging global knowledge commons… These are but some of the outcomes of a growing movement that champions globally-sourced designs for local economic activity. Its core idea is simple: local ownership of the means to produce basic manufactures and services can change our economic paradigm, making our cities self-sufficient and help the planet.”
source: Cosmo-localization': can thinking globally and producing locally really save our planet?
I think this is especially important to think about cosmolocalism in the context of decolonization of science, health (human bodies) and even open science. And what draws me to continually work with the Open Insulin group is that the agency in the knowledge-production is not contingent on a colonial mindset, even at this stage in collaboration.
In practice, what this means is that the Mboa labs for example, could produce their own insulin, create media (as @ThomasMboa has done on Facebook around diabetes awareness and insulin), storytelling, foster partnerships and strategies, wholly rooted in the the local context. This is what I think success would look like for the OpenInsulin project, globally.
Last, there is the idea of launching a patient coop for OI, which we’d like to plan for the patients and producers controlling not only processes, but also the valuable health data that are produced from say, controlled trials. This kind of coop in theory, could allow individual actors to own the data that has traditionally been owned by corporations. We are also hoping this kind of coop would allow the technology to get into the hands of those who need it quickly, and not have to wait on the beauracratic processes in place that are oftentimes onerous and significantly slowing, and not always centered around the humans that should really have more say about how they want to create health in their own bodies and also their communities, local and beyond.
